Ballerup, Denmark

Krister Henriksson

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Leo-Pharma A/s. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Krister Henriksson. Retrieved from https://idiyas.com/inventor/krister-henriksson-y64teewk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Krister Henriksson: Innovator in Pharmaceutical Science

Introduction

Krister Henriksson is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug delivery systems. His work focuses on non-steroidal glucocorticoid receptor modulators, which have important therapeutic applications.

Latest Patents

Henriksson holds a patent for "Non-steroidal glucocorticoid receptor modulators for local drug delivery." This invention relates to a compound characterized by a specific formula, which includes various chemical groups and structures. The patent outlines the use of these compounds in therapy, their preparation, and their incorporation into pharmaceutical compositions. The invention aims to improve the efficacy of drug delivery systems and offers potential benefits in treating various diseases. He has 1 patent to his name.

Career Highlights

Krister Henriksson is associated with Leo Pharma A/S, a company renowned for its focus on dermatology and critical care. His work at Leo Pharma has allowed him to explore innovative solutions in drug formulation and delivery. His contributions have been instrumental in advancing therapeutic options for patients.

Collaborations

Henriksson has collaborated with notable colleagues, including Patrick Stephen Johnson and Kevin Neil Dack. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in pharmaceutical research.

Conclusion

Krister Henriksson's work exemplifies the impact of innovation in the pharmaceutical industry. His patent on glucocorticoid receptor modulators highlights his commitment to improving drug delivery systems. Through his career at Leo Pharma and collaborations with esteemed colleagues, Henriksson continues to contribute to advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…